ExploreTreatments
ED Care ComparisonExpert analysis updated June 2026

DirectMax vs MEDVi QUAD: Which Telehealth ED Treatment Works Better? (2026)

DirectMax and MEDVi QUAD are two of the leading multi-ingredient compounded ED treatments available through telehealth. Both combine prescription ingredients to target arousal, erection quality, and duration in a single dose, but they differ on formula depth, delivery method, and price. DirectMax offers a triple-action rapid dissolve tablet starting at $7.45 per dose. MEDVi QUAD adds a fourth ingredient (Vardenafil) and uses sublingual liquid delivery for potentially faster, food-independent onset, starting at $114 for a 5-pack (with a $179 10-pack).

Our Verdict

Neither is an outright winner, the right pick depends on your priorities. DirectMax suits men who want proven triple-action coverage at the lowest possible per-dose entry price. MEDVi QUAD suits men who want the most comprehensive multi-pathway formula and fastest sublingual onset.

Side-by-Side Feature Comparison

FeatureDirectMaxMEDVi QUADWinner
Formula Type3-in-1 (Apomorphine + Sildenafil + Tadalafil)4-in-1 (Apomorphine + Vardenafil + Sildenafil + Tadalafil)MEDVi QUAD
Delivery MethodRapid dissolve tabletSublingual liquid (under the tongue)MEDVi QUAD
Onset Time~15 minutes10–15 minutesMEDVi QUAD
Duration WindowUp to 36 hoursUp to 36 hoursTie
Starting PriceFrom $7.45/dose$114 (5-pack) / $179 (10-pack)DirectMax
Vardenafil IncludedNoYesMEDVi QUAD
Food InteractionStandard tablet, may be affected by mealsSublingual, less affected by foodMEDVi QUAD
No-Charge If Not ApprovedNot statedYesMEDVi QUAD
Prescription RequiredYesYesTie

Pros and Cons

DirectMax

Pros

  • Lowest per-dose entry price in the multi-ingredient ED category (from $7.45/dose)
  • Triple-action formula targets arousal, firmness, and duration
  • Rapid dissolve tablet format for convenient, discreet use
  • Fully online medical evaluation, no clinic visit required
  • Discreet plain-packaging home delivery
  • 300,000+ men have started the evaluation process

Cons

  • Three ingredients vs four in MEDVi QUAD, no Vardenafil
  • Standard tablet format more susceptible to food timing than sublingual
  • No-charge-if-not-approved policy not explicitly stated
  • Individual results vary by health profile and dosage

Best For

Men who want multi-action ED coverage, addressing desire, firmness, and duration, at the lowest possible per-dose price point.

MEDVi QUAD

Pros

  • Four-ingredient formula covers the most treatment pathways in one dose
  • Sublingual liquid for fastest possible absorption (10–15 min)
  • Less affected by meals than swallowed tablets
  • Up to 36-hour response window with no strict timing pressure
  • No charge if clinician does not approve the prescription
  • Ongoing clinical support included in monthly plan

Cons

  • Higher entry cost at $114 (5-pack) / $179 (10-pack) vs per-dose DirectMax pricing
  • Monthly subscription model, less flexibility than per-dose pricing
  • Liquid sublingual format not preferred by all users
  • Limited independent research on the specific 4-ingredient combined formulation

Best For

Men who want the most comprehensive multi-pathway formula with the fastest sublingual onset and the least dependence on meal timing.

Frequently Asked Questions: DirectMax vs MEDVi QUAD

DirectMax starts at $7.45 per dose, making it more accessible on a per-dose basis. MEDVi QUAD is priced at $114 for a 5-pack and $179 for a 10-pack, which includes consultation, prescription, medication, shipping, and ongoing support. Which is cheaper depends on how frequently you use the medication and whether you prefer per-dose or pack pricing.
A rapid dissolve tablet (DirectMax) breaks down quickly in the mouth and is absorbed through the digestive system. A sublingual liquid (MEDVi QUAD) is held under the tongue and absorbed directly through the mucous membranes into the bloodstream, bypassing digestion. Sublingual delivery is generally faster and less affected by food.
MEDVi QUAD targets a 10–15 minute onset via sublingual absorption. DirectMax also targets approximately 15 minutes. In practice, MEDVi QUAD's sublingual format may offer a more consistent onset regardless of whether you've eaten recently, while a swallowed tablet can be slowed by a large or fatty meal.
Neither multi-ingredient compounded formula is typically the recommended starting point for first-time ED treatment. A lower-cost generic single-ingredient option (sildenafil or tadalafil) is usually the first step recommended by clinicians. If you have already tried generics without satisfactory results, both DirectMax and MEDVi QUAD may be worth discussing with a licensed provider.
Yes. Both are prescription-only compounded medications that require a licensed clinician to review your health history before a prescription is issued. Neither is sold over the counter.
MEDVi QUAD adds Vardenafil, a PDE5 inhibitor known for rapid activation, to the Apomorphine, Sildenafil, and Tadalafil combination found in DirectMax. This fourth ingredient targets fast onset speed alongside the broader arousal and duration coverage shared by both formulas.

ED Care Guides

Compare All ED Care Providers

See the full ranked list of ed care providers side-by-side with ratings and pricing.

View All Providers

Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.

Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.

Editorial Standards: Independent research · Evidence-based analysis · Transparent methodology · 2026